Clinical Trials Browser

NETWORK × Melanoma × romidepsin × Clear all

NCT00104884 2023-06-28

FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma

Phase 2 Terminated

4 enrolled 4 charts

Melanoma